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Abstract
The study aimed to investigate the association between metabolic syndrome (MetS) and lifestyle risk factors among Ellisras
adults. A cross-sectional study was conducted on 624 adults (306 males and 318 females). MetS was deﬁned according to
the criteria of the International Diabetes Federation. The prevalence of MetS was 23.1% (8.6% males and 36.8 % females).
Females appeared to have higher mean values for waist circumference (WC), fasting blood glucose (FBG), total cholesterol
(TCHOL) and low-density lipoprotein cholesterol (LDL-C), while males had high mean values for high-density lipoprotein
cholesterol (HDL-C), triglycerides (TG), systolic blood pressure (SBP) and diastolic blood pressure (DBP). No signiﬁcant
age and gender differences were observed for dietary intake. Signiﬁcantly more females (51.9%) presented with increased
WC than males (4.6%). Participants who had a high dietary energy intake were signiﬁcantly less likely to present with larger
WC (OR: 0.250 95% CI [0.161; 0.389]), low HDL-C (OR: 0.306 95% CI [0.220; 0.425]) and high LDL-C (OR: 0.583 95%
CI [0.418; 0.812]) but more likely to present with elevated FBG (OR: 1.01 95% CI [0.735; 1.386]), high TCHOL (OR: 1.039
95% CI [0.575; 1.337]), high TG (OR: 1.186 95% CI [0.695; 2.023]) and hypertension (OR: 5.205 95% CI [3.156; 8.585]).
After adjusting for age, gender, smoking, and alcohol status, high energy intake was more than two times likely to predict
MetS in adults with a large WC (OR: 2.766 95% CI [0.863; 3.477] and elevated FBG (OR: 2.227 95% CI [1.051; 3.328]).
Therefore, identifying groups that are at an increased risk and those that are in their early stages of MetS will help improve
and prevent the increase of the MetS in the future.
Introduction
Metabolic syndrome (MetS) is a global problem associated
with the clustering of several cardiovascular risk factors [1, 2].
Contrary to earlier thoughts, MetS is no longer rare in
Africa, especially in medium-income countries such as
South Africa [3]. South African evidence suggests an
upsurge of non-communicable diseases (NCDs) amidst the
existence of communicable diseases (CDs) such as HIV/
AIDS and tuberculosis. Moreover, NCDs and CDs in the
country are inﬂuenced by socio-demographic factors; and
thus tend to be more prominent in certain segments of the
population [1, 4–6]. The South African population is
comprised of various ethnic groups [7]. Patterns of NCDs
and CDs in this regard understandably vary by ethnicity,
possibly due to ethnic and cultural differences. More
importantly, the rise in NCDs in the country can be
explained by the rapid nutrition transition associated with
urbanization, the adoption of “Westernized” diets (diets
high in fat, added sugar, and salt) and lifestyles (sedentary
activity, excessive alcohol intake, and smoking) as well as
the diversity of cultural and ethnic beliefs [8, 9].
Among others, the consequences of the aforementioned
diet and lifestyle are insulin resistance, hyperinsulinaemia,
central obesity, hypertension, elevated total cholesterol
(TCHOL) and low-density lipoprotein cholesterol (LDL-C),
dyslipidaemia (increase in plasma triglycerides [TG]) and a
* K. D. Monyeki
kotsedi.monyeki@ul.ac.za
1 Department of Physiology and Environmental Health, University
of Limpopo, Polokwane, South Africa
2 Population Health, Health System and Innovations, Human
Science Research Council, Cape Town, South Africa
3 Department of Biochemistry, Sefako Makgatho, Health Science
University, Pretoria, South Africa
4 Faculty of Community and Health Sciences, School of Public
Health, University of the Western Cape, Bellville, South Africa
5 Department of Pathology and Medical Sciences, University of
Limpopo, Polokwane, South Africa
12
34
56
78
90
()
;,:
12
34
56
78
90
();
,:
decrease in high-density lipoprotein cholesterol (HDL-C).
Substantial evidence suggests that these consequences are
components of MetS [1, 2]. Furthermore, there is evidence
that emphasizes obesity as the main component of MetS
[1, 2, 10]. Obesity is deﬁned as the accumulation of excess
body fat, which manifests as increased weight, or the cen-
tralization of body fat (indicated as higher than normal waist
circumference (WC)) [1]. In Africa, different measures of
body fat accumulation have been used as primary indicators
for MetS. For instance, some studies emphasize body mass
index (BMI), while others emphasize WC or waist-to-hip
ratio (WHR) as the standard measures for MetS. In
Cameroon, researchers used WHR (WHR>0.9 (males) and
>0.85 (females) to measure body fat centralization in rural
dwellers, while they used WC (as deﬁned by both National
Cholesterol Education Program (NCEP) and International
Diabetes Federation (IDF)) in urban dwellers [10]. In South
Africa, WC (≥86 cm for men and ≥92 cm for women) has
been used as a predictor of the presence of at least two other
components of MetS in a rural South African black com-
munity in KwaZulu-Natal [4]. In this study, it was also
shown that MetS was more prevalent in women than in
men. In fact, in South Africa metabolic diseases are
expected to increase dramatically in women due to the
rising rates of obesity and dyslipidaemia in this gender [11].
Body fat centralization was also deﬁned according to the
World Health Organization (WHO) classiﬁcation as WC
(≥102 cm and ≥88 cm for males and females, respectively)
in Benin, while BMI was used in Gambia (≥30 kg/m2) and
Nigeria (≥25–29.9 kg/m2 and ≥30 kg/m2) [12, 13]. This
therefore poses signiﬁcant challenges for country compar-
isons of the extent of MetS on the African continent.
However, it is important to be cognisant of the pivotal role
that the accumulation of body fat, particularly central obe-
sity, plays in the aetiology of MetS in all these African
studies [4, 10–13].
Moreover, it is important to be mindful of the other risk
factors for MetS, namely, unhealthy diets and risky life-
styles [1, 2]. For example, the current diet consumed by
South Africans needs close monitoring as it is thought to
fuel the prevalence of MetS in the country [14]. In fact, the
consumption of high-fat and high-sugar diets, especially by
those who have ﬁnancial constraints is undesirable. Most
South African households cannot afford a healthy diet and
therefore rely on a diet that is, in most cases, energy dense
(high in added sugar and total fat) and high in salt and
saturated fat, while it is deﬁcient in nutrients [15]. This diet
therefore inﬂuences the blood biochemical proﬁle of the
individuals who consume it, thereby subjecting them to
metabolic diseases.
The study aimed to investigate the association between
MetS and lifestyle risk factors among young rural South
African adults aged 18–30 years. This age group was
selected since young adults in rural South Africa have been
identiﬁed as having a high risk of being undiagnosed for
NCDs [16, 17]. Emphasis was placed on differentiating the
risk of MetS by age and gender. The outcomes of the cur-
rent study therefore will contribute to MetS prevention
efforts, especially in vulnerable populations, namely, rural
and young South Africans [4, 17].
Methods
Geographical area
Ellisras (known as Lephalale) is considered as one of the
deep rural areas in the western part of the Limpopo province
in South Africa. The villages are approximately 70 km
away from the Ellisras town (23°40 S 27°44W), adjacent to
the Botswana border. The population is about 50,000 dis-
persed across 42 settlements [18]. The main sources of
employment for the Ellisras residents are the Iscor coal
mine and Matimba electricity power station. The remaining
workforce mostly is involved in subsistence farming and
cattle rearing, while a few are involved in education and
civil services. Poverty, unemployment, and low life
expectancy plays an important role in rural South African
settings and the Ellisras rural population is not exempted
from this [19].
Sample and research design
A total of 624 adults (306 males and 318 females) aged
18–30 years who are part of the Ellisras Longitudinal Sur-
vey (ELS) participated in the current study [20, 21]. The
Ethics Committee of the University of Limpopo granted
ethical approval prior to the survey and the participants
signed the informed consent forms.
Data collection
Dietary intake
Dietary intake was measured using a validated 24 h recall
method [22]. Senior Northern Sotho-speaking dietetic stu-
dents of the University of Limpopo, speciﬁcally those
trained to use the 24-h recall method, completed interviews
with participants regarding their dietary intake over the
previous 24 h. For each participant, interviews took place on
one weekday and on one weekend day. An average of
2 days 24-h dietary intake was then made for each partici-
pant. Estimated portion sizes of foods consumed were
recorded in as much detail as possible, using a pretested
questionnaire and food models, simulating average portions
of local foods [23]. A self‑administered questionnaire was
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used to collect data on lifestyle factors, including smoking
and alcohol intake.
Anthropometric and blood pressure (BP) measurements
Anthropometric measurements (WC) were conducted on all
study participants, according to standard procedures of the
International Society for the Advancement of Kinan-
thropometry [24]. The WC measurements were taken to the
nearest 0.1 cm, using a soft measuring tape.
Using an electronic Micronta Monitoring Kit, three BP
readings were taken after the subject had been seated for 5
min or longer. The bladder of the device contains an elec-
tronic infrasonic transducer that monitors the BP and pulse
rate, displaying these concurrently on the screen. This
versatile instrument has been designed for research and
clinical purposes [25].
Biochemical parameters
Fasting venous blood specimens were collected from all the
participants for the measurement of fasting blood glucose
(FBG), TCHOL, TG and HDL-C. Blood specimens for the
measurement of fasting plasma glucose (FVPG) were drawn
into ﬂuoride tubes. The FVPG was measured using the
glucose oxidase method, on a Beckman LX20® auto-
analyser (Beckman Coulter, Fullerton, CA) after the sam-
ples were centrifuged within 4 h. The enzymatic assay kits
on a Beckman LX20® auto-analyser (Beckman Coulter,
Fullerton, CA) were used to measure serum lipid proﬁle.
High LDL-C was calculated using Friedewald equation
[26]:
ð LDL C½  ¼ TCHOL½   HDL C½   triglyceride½ =5Þ
Criteria for MetS diagnosis
MetS was diagnosed using the new harmonized guidelines
of the IDF, which requires large (WC) (≥94 cm males, ≥80
cm females plus two of the following criteria: reduced
HDL-C (<1.0 mmol/L males; <1.3 mmol/L females), high
TG (≥1.7 mmol/L), elevated BP (≥130 mmHg systole and/
or ≥85 mmHg diastole), FBG (≥5.6 mmol/L) [27] and high
LDL-C (≥3 mmol/L) [28].
Statistical analysis
Descriptive statistics were used to describe the participant’s
characteristics and data were presented using numbers,
percentages, medians, means, and standard deviations.
Linear regression was used to investigate the association
between dietary intake and MetS risk factors. Dietary intake
variables used in the linear regression method were log
transformed prior to analysis because of their skewed dis-
tribution. Logistic regression analysis was used to investi-
gate the inﬂuence of dietary intake on MetS risk factors.
The statistical package of the social sciences (SPSS) version
23.0 was used for data analysis. A p-value of <0.05 was
considered statistically signiﬁcant. Dietary data were ana-
lysed using local food tables and software [29] and com-
pared to the recommended intake [30].
Results
Table 1 shows the mean values for the MetS risk factors and
dietary intake of the participants. Overall, females appear to
have higher mean values for WC, FBG, TCHOL and LDL-C,
while males have high mean values for HDL-C, TG, SBP
and DBP. This trend is consistent, when disaggregating the
sample by age groups. However, the only signiﬁcant dif-
ferences between males and females were recorded for WC
(75.09 ± 9.53 and 82.14 ± 14.37, respectively) and SBP
(125.91 ± 12.78 and 114.23 ± 10.84, respectively), with this
signiﬁcant gender difference also visible in the 25–30-year-
old group. With regard to differences between age groups,
most risk factors were more prevalence in the older age
group (25–30 years), except for FBG and HDL-C (5.56 ±
0.91 and 1.16 ± 0.31, respectively) that were higher in the
18–24-year-old group compared to 1.16 ± 0.31) and 1.14 ±
0.35, respectively) in the 25–30-year-old group). There
were no signiﬁcant differences between age groups for all
the measured risk factors except for the DBP where the
mean value was 68.78 ± 9.37) in the 18–24-year-old group
compared to 70.96 ± 10.05 in the 25–30-year-old group (p
< 0.05). While no signiﬁcant differences were observed for
dietary intake between males and females, the largest dif-
ference observed between males and females were for
energy intake, where females had a higher median energy
intake than males [3474 (3482.00) vs 3029.0 (3874.00),
respectively]. This relationship was different when the data
was disaggregated by age in that, in the 18–24-year-old age
group, males reported a higher energy intake [3520.00
(3646.50)] than females [3314.00 (2919.00)], whereas
females reported a higher energy intake [3674.00
(3992.50)] than males [2886.00 (3967.00)] in the 25–30-
year-old group. With regard to macronutrients, females
consumed more carbohydrates, added sugar, ﬁbre and
saturated fat; while males consumed more total fats, pro-
teins, monounsaturated and polyunsaturated fats.
Figure 1a shows the observed prevalence of each MetS
risk factor of the total sample of participants. Overall, sig-
niﬁcantly more females presented with increased WC than
males (51.9 vs 4.6%). The trend of gender differences was
also observed for elevated TCHOL (22.0% for females vs
11.1% for males) and LDL-C (42.8% for females vs 26.8%
The risk of metabolic syndrome as a result of lifestyle among Ellisras rural young adults
Ta
bl
e
1
D
es
cr
ip
tiv
e
st
at
is
tic
fo
r
m
et
ab
ol
ic
sy
nd
ro
m
e
ri
sk
fa
ct
or
s
of
E
lli
sr
as
ad
ul
ts
by
ag
e
gr
ou
p
an
d
ge
nd
er
R
is
k
fa
ct
or
s
18
–
24
ye
ar
s
25
–
30
ye
ar
s
18
–
30
ye
ar
s
M
al
es
(n
=
10
3)
F
em
al
es
(n
=
10
1)
T
ot
al
(N
=
20
4)
M
al
es
(n
=
20
3)
F
em
al
es
(n
=
21
7)
T
ot
al
(N
=
42
0)
M
al
es
(n
=
30
6)
F
em
al
es
(n
=
31
8)
T
ot
al
(N
=
62
4)
M
ea
n
±
S
D
M
ea
n
±
S
D
M
ea
n
±
S
D
M
ea
n
±
S
D
M
ea
n
±
S
D
M
ea
n
±
S
D
M
ea
n
±
S
D
M
ea
n
±
S
D
M
ea
n
±
S
D
W
C
(c
m
)
72
.0
7
±
7.
27
78
.0
5
±
13
.3
6
75
.0
3
±
11
.1
1
76
.6
2*
±
10
.1
7
84
.0
4*
±
14
.4
6
80
.4
6
±
13
.0
9
75
.0
9*
±
9.
53
82
.1
4*
±
14
.3
7
78
.6
8
±
12
.7
3
F
B
G
(m
m
ol
/L
)
5.
54
±
0.
91
5.
78
±
0.
91
5.
56
±
0.
91
5.
40
±
0.
84
5.
63
±
1.
77
1.
16
±
0.
31
5.
45
±
0.
87
5.
62
±
1.
55
5.
53
±
1.
26
T
C
(m
m
ol
/L
)
4.
02
±
0.
87
4.
07
±
1.
03
4.
04
±
0.
95
4.
04
±
0.
95
4.
35
±
1.
13
4.
20
±
1.
06
4.
03
±
0.
92
4.
62
±
1.
11
4.
15
±
1.
03
H
D
L
-C
(m
m
ol
/L
)
1.
23
±
0.
34
1.
09
±
0.
28
1.
16
±
0.
31
1.
19
±
0.
39
1.
10
±
0.
31
1.
14
±
0.
35
1.
20
±
0.
37
1.
10
±
0.
30
1.
15
±
0.
34
T
G
(m
m
ol
/L
)
0.
96
±
0.
60
0.
87
±
0.
48
0.
92
±
0.
54
1.
11
±
0.
67
1.
00
±
0.
52
1.
05
±
0.
60
1.
06
±
0.
65
0.
96
±
0.
51
1.
01
±
0.
59
L
D
L
-C
(m
m
ol
/L
)
2.
61
±
0.
71
2.
80
±
0.
89
2.
71
±
0.
81
2.
63
±
0.
81
3.
05
±
0.
96
2.
85
±
0.
92
2.
62
±
0.
78
2.
97
±
0.
95
2.
80
±
0.
89
S
B
P
(m
m
H
g)
12
3.
20
±
12
.3
0
11
2.
61
±
9.
16
11
7.
95
±
12
.0
6
12
7.
29
*
±
12
.3
7
11
4.
98
*
±
11
.4
9
12
0.
93
±
13
.4
1
12
5.
91
**
±
12
.7
8
11
4.
23
**
±
10
.8
4
11
9.
96
±
13
.0
5
D
B
P
(m
m
H
g)
68
.8
9
±
9.
58
68
.6
6
±
9.
20
68
.7
8*
±
9.
37
72
.7
3
±
10
.3
5
69
.3
1
±
9.
50
70
.9
6*
±
10
.0
5
71
.4
4
±
10
.3
4
69
.1
0
±
9.
39
70
.2
5
±
9.
88
D
ie
ta
ry
in
ta
ke
M
ed
ia
n
(I
Q
R
)
M
ed
ia
n
(I
Q
R
)
M
ed
ia
n
(I
Q
R
)
M
ed
ia
n
(I
Q
R
)
M
ed
ia
n
(I
Q
R
)
M
ed
ia
n
(I
Q
R
)
M
ed
ia
n
(I
Q
R
)
M
ed
ia
n
(I
Q
R
)
M
ed
ia
n
(I
Q
R
)
E
ne
rg
y
(k
j)
35
20
.0
0
(3
64
6.
50
)
33
14
.0
0
(2
91
9.
00
)
34
86
.0
0
(3
29
9.
50
)
28
86
.0
0
(3
96
7.
50
)
36
74
.0
0
(3
99
2.
50
)
32
13
.5
0
(3
95
3.
50
)
30
29
.0
(3
87
4.
00
)
34
74
(3
48
2.
00
)
33
10
.0
(3
59
1.
00
)
F
at
ty
ac
id
s
(%
)
23
.1
8
(1
7.
73
)
20
.7
1
(2
2.
37
)
21
.4
3
(2
0.
01
)
22
.2
2
(2
6.
10
)
22
.7
5
(2
5.
80
)
22
.5
0
(2
6.
80
)
22
.6
(2
1.
51
)
22
.1
(2
4.
26
)
22
.3
(2
3.
50
)
P
ro
te
in
(%
)
14
.4
8
(1
1.
67
)
11
.5
5
(9
.2
4)
13
.1
7
(1
0.
45
)
12
.0
7
(1
3.
75
)
11
.6
8
(1
2.
78
)
12
.0
3
(1
3.
36
)
12
.9
(1
2.
34
)
11
.7
(1
1.
19
)
12
.3
(1
1.
76
)
C
ar
bo
hy
dr
at
e
(%
)
61
.8
1
(2
4.
49
)
65
.9
8
(2
8.
80
)
63
.3
1
(2
3.
73
)
63
.7
6
(3
5.
57
)
62
.2
9
(3
3.
42
)
62
.7
9
(3
4.
60
)
62
.8
(3
0.
82
)
63
.7
(3
0.
91
)
63
.0
(3
1.
41
)
A
dd
ed
su
ga
r
(g
)
24
.4
0
(3
9.
83
)
34
.7
0
(4
9.
30
)
27
.7
0
(4
0.
65
)
24
.0
0
(4
9.
70
)
25
.8
0
(3
8.
45
)
25
.8
0
(3
9.
90
)
24
.0
(4
5.
50
)
26
.0
(3
6.
00
)
25
.8
(3
9.
50
)
F
ib
re
(g
)
5.
60
(8
.1
8)
5.
90
(7
.8
0)
5.
70
(7
.8
5)
3.
80
(7
.1
5)
4.
80
(9
.8
5)
4.
05
(8
.4
3)
4.
3
(7
.0
0)
5.
1
(9
.0
0)
4.
6
(8
.4
0)
S
F
A
s
(%
)
5.
83
(6
.4
2)
4.
56
(8
.4
2)
5.
28
(7
.7
5)
4.
14
(1
0.
06
)
5.
28
(1
0.
62
)
5.
02
(1
0.
44
)
4.
8
(8
.5
4)
5.
0
(9
.9
1)
4.
9
(9
.3
6)
M
U
F
A
s
(%
)
8.
20
(9
.5
5)
5.
39
(1
0.
50
)
6.
67
(1
0.
03
)
5.
19
(1
3.
77
)
6.
97
(1
4.
95
)
6.
48
(1
4.
79
)
6.
6
(1
1.
75
)
6.
4
(1
4.
01
)
6.
5
(1
2.
90
)
P
U
F
A
s
(%
)
5.
07
(7
.3
7)
2.
97
(7
.6
7)
4.
02
(7
.6
3)
2.
97
(7
.7
4)
4.
16
(8
.6
1)
3.
44
(8
.3
9)
3.
7
(7
.5
7)
3.
4
(8
.1
8)
3.
7
(7
.9
5)
T
ra
ns
fa
tty
ac
id
s
(%
)
0.
18
(1
.1
0)
0.
12
(1
.0
5)
0.
14
(1
.0
5)
0.
12
(0
.4
0)
0.
12
(1
.2
7)
0.
12
(0
.8
1)
0.
1
(0
.4
9)
0.
1
(1
.1
7)
0.
1
(0
.9
5)
D
at
a
on
lip
id
pr
oﬁ
le
an
d
an
th
ro
po
m
et
ry
ar
e
pr
es
en
te
d
as
m
ea
n
±
S
D
,
w
hi
le
di
et
ar
y
in
ta
ke
da
ta
ar
e
pr
es
en
te
d
as
m
ed
ia
n
(I
Q
R
)
n
nu
m
be
r
of
pa
rt
ic
ip
an
ts
,
W
C
w
ai
st
ci
rc
um
fe
re
nc
e,
F
B
G
fa
st
in
g
bl
oo
d
gl
uc
os
e,
T
C
to
ta
l
ch
ol
es
te
ro
l,
H
D
L
hi
gh
-d
en
si
ty
lip
op
ro
te
in
,
L
D
L
lo
w
-d
en
si
ty
lip
op
ro
te
in
,
T
G
tr
ig
ly
ce
ri
de
s,
C
H
O
ca
rb
oh
yd
ra
te
s,
SB
P
sy
st
ol
ic
bl
oo
d
pr
es
su
re
,D
B
P
di
as
to
lic
bl
oo
d
pr
es
su
re
,S
F
A
sa
tu
ra
te
d
fa
tty
ac
id
, M
U
F
A
m
on
ou
ns
at
ur
at
ed
fa
tty
ac
id
,P
U
F
A
po
ly
un
sa
tu
ra
te
d
fa
tty
ac
id
,T
F
A
tr
an
s
fa
tty
ac
id
,I
Q
R
in
te
rq
ua
rt
ile
ra
ng
e
**
p
<
0.
00
1;
*p
<
0.
05
M. D. Sekgala et al.
n=14 n=135 n=34 n=90 n=33 n=82 n=101 n=28 n=104
n=165
n=154
n=70
n=247
n=29
n=138
n=25
n=16[VALUE]
n=30
n=179
n=289
n=104
n=337
n=62
n=218
n=126
n=44
n=134
0
10
20
30
40
50
60
70
80
90
High WC Elevated FBG High CHOL Reduced HDL-C Elevated TG Increased LDL-C Increased SBP Increased DBP Hypertension
Pr
ev
al
en
ce
 o
f M
et
S 
ris
k 
fa
ct
or
s
MetS risk factors
18-30 years
Males Females Total
**
**
**
**
**
**
**
*
*
*
*
n=2 n=50 n=11 n=25 n=7 n=26 n=24 n=8 n=24
n=38
n=47
n=17
n=78
n=9
n=32
n=5 n=6 n=9
n=40
n=97
n=28
n=103
n=16
n=58
n=29
n=14
n=33
0
10
20
30
40
50
60
70
80
90
High WC Elevated FBG High CHOL Reduced HDL-C Elevated TG Increased LDL-C Increased SBP Increased DBP Hypertension
Pr
ev
al
en
ce
 o
f M
et
S 
ris
k 
fa
ct
or
s
MetS risk factors
18-24 years
Males Females Total
**
**
** *
*
*
*
*
n=12
n=85
n=23
n=65
n=26
n=56
n=77
n=20
n=80
n=127 n=107
n=53
n=169
n=20
n=104
n=20 n=10
n=21
n=139 n=192
n=76
n=234
n=46
n=160
n=97
n=30
n=101
0
10
20
30
40
50
60
70
80
90
High WC Elevated FBG High CHOL Reduced HDL-C Elevated TG Increased LDL-C Increased SBP Increased DBP Hypertension
Pr
ev
al
en
ce
 o
f M
et
S 
ris
k 
fa
ct
or
s
MetS risk factors
25-30 years
Males Females Total
**
**
**
**
*
**
a
b
c
Fig. 1 a Prevalence of the metabolic syndrome risk factors in the total
sample, males and females in the age group 18–30 years of Ellisras
young adults. b Prevalence of metabolic syndrome risk factors in the
total sample, males and females in the age group 18–24 years of
Ellisras young adults. c Prevalence of metabolic syndrome risk factors
in the total sample, males and females in the age group 25–30 years of
Ellisras young adults
The risk of metabolic syndrome as a result of lifestyle among Ellisras rural young adults
for males), as well as the reduced HDL-C (77.7% for
females vs 29.4% for males). Conversely, signiﬁcantly
more males presented with increased SBP (p < 0.001), DBP
(p < 0.05) and hypertension (p < 0.001), (33.0, 9.2 and
34.0%, respectively) when compared to their female coun-
terparts (7.9, 5.0 and 9.4%, respectively). Overall, the risk
factors with the highest prevalence were reduced HDL-C,
elevated FBG and increased LDL-C (ranging from 54.0,
46.3 and 34.9%, respectively). The risk factors with the
lowest prevalence were increased DBP, increased TG and
high TCHOL (ranging from 7.1, 9.9 and 16.7%,
respectively).
The gender difference trend was observed even when the
sample data was disaggregated by age groups (Fig. 1b) in
that signiﬁcantly more females aged 18–24 years presented
with larger WC and reduced HDL (37.6 and 77.2%,
respectively) than males (1.9 and 24.3%, respectively).
Males in the 18–24-year-old group had signiﬁcantly high
DBP and hypertension than females (23.3 vs 5.0% and 23.3
vs 8.9%, respectively). Overall, the risk factors with the
highest prevalence in this particular age group were reduced
HDL-C, elevated FBG and increased LDL-C (ranging from
50.5, 47.5 and 28.4%, respectively). The risk factors with
the lowest prevalence were increased DBP, elevated TG and
high TCHOL (ranging from 6.9, 7.8 and 13.7%,
respectively).
Consistency trends were observed in the 25–30-year-old
group (Fig. 1c), as large WC and reduced HDL-C were
signiﬁcantly higher in more females than males (58.5 vs
5.9% and 77.9 vs 32.0%, respectively). In addition, sig-
niﬁcantly more females (24.4%) had elevated TCHOL than
males (11.3%). Similarly, as observed in the 18–24-year-old
group, more males than females presented with high SBP
(37.9 vs 9.2%), DBP (9.9 vs 4.6%) and hypertension (39.4
vs 9.7%), respectively). Overall, the risk factors with the
highest prevalence in the 25–30-year-old group were
reduced HDL-C, elevated FBG and increased LDL-C
(ranging from 55.7, 45.7 and 38.1%, respectively). The
lowest prevalence risk factors are increased DBP, elevated
TG and high TCHOL (ranging from 7.1, 11.0 and 18.1%,
respectively).
With regard to dietary intake, overall, signiﬁcantly more
males than females reported a high total energy (95.8 vs
17.6%), high protein (5.9 vs 1.6%) and low ﬁbre intake
(99.3 vs 96.2%). This trend remained signiﬁcant for a high
total energy when data were disaggregated by age group,
where 99.0% of males within the 18–24-year-old group had
high total energy intake compared to 7.9% females and
94.1% of males within the 25–30-year-old group had high
total energy intake compared to 22.1% females. However,
the trend for a high protein and low ﬁbre intake only
remained signiﬁcant in the 25–30-year-old group where and
7.4 and 99.5% of males reported a high protein and low
ﬁbre intake compared to 1.8 and 95.9% of females,
respectively.
On the other hand, as shown in Table 2, more females
reported a high added sugar intake compared to males (56.9
vs 48.4%). This remained signiﬁcant in the 18–24-year-old
group where 66.3% of females reported a high prevalence
of added sugar compared to 48.5% of males. In the 25–30-
year-old group, signiﬁcantly more females (27.6%) reported
intakes of high trans fatty acid diets compared to males
(17.7%).
With regard to age groups, the only signiﬁcant difference
observed was for reported intake of high protein, where more
people in the 25–30-year-old group (4.5%) reported a high
protein intake than those in the 18–24-year old group (2.0%).
It is important to note that the details of the outcomes for
MetS are presented elsewhere [31]. A snapshot of these
outcomes are as follows: Overall, the total prevalence of
MetS was 23.1% (8.6% males and 36.8% females). When
the sample data was disaggregated by age groups, the pre-
valence of MetS in the 18–24-year-old group was 20.1%
(9.8% males and 30.8% females) and 25.0% (7.7% males
and 30.8% females) in the 25–30-year-old group.
Table 3 shows the linear regression analysis undertaken
to show the association of each log dietary intake variables
with different MetS risk factors. The results showed no
association between log total energy, log added sugar, log
saturated fatty acid (SFA) and log monounsaturated fatty
acid (MUFA) with metabolic risk factors. There was a low
and negative signiﬁcant association between log ﬁbre with
SBP and DBP (β:−0.004, p= 0.003 and β:−0.004, p=
0.046), respectively. After adjusting for potential con-
founding factors, log ﬁbre was also associated with FBG (β:
−0.028, p= 0.046). Log polyunsaturated fatty acids
(PUFAs) was inversely associated with FBG, HDL-C and
SBP crude. Log trans fatty acids was inversely associated
with WC, HDL-C and SBP crude. Both log PUFAs and log
trans fatty acids were not associated with any metabolic risk
factors after adjusting for potential confounding factors.
Log protein was inversely associated with SBP both crude
and adjusted for potential confounding factors.
Table 4 shows that participants who had high dietary
energy intake were signiﬁcantly less likely to present with
larger WC (odds ratio (OR): 0.250 95% conﬁdence interval
(CI) [0.161; 0.389]), low HDL-C (OR: 0.306 95% CI
[0.220; 0.425]) and high LDL-C (OR: 0.583 95% CI [0.418;
0.812]) but more likely to present with elevated FBG (OR:
1.01 95% CI [0.735; 1.386]), high TCHOL (OR: 1.039 95%
CI [0.575; 1.337]), high TG (OR: 1.186 95% CI [0.695;
2.023] and hypertension (OR: 5.205 95% CI [3.156; 8.585])
crude. After adjusting for age, gender, smoking and alcohol
status, high energy intake was more than two times more
likely to predict MetS in adults with a large WC (OR: 2.766
95% CI [0.863; 3.477] and elevated FBG (OR: 2.227 95%
M. D. Sekgala et al.
CI [1.051; 3.328]). Furthermore, low dietary ﬁbre intake
was nearly four time more likely to increase low HDL-C
(OR: 3.864 95% CI [1.067; 13.988]) crude.
Those participants who consumed high trans fats were
more likely to present with high FBG (OR:1.424 95% CI
[0.985; 2.060]) but less likely to present with high LDL-C
(OR: 0.540 95% CI [0.321; 0.906]) crude. However, after
adding potential confounding factors, participants with high
fatty acid were less likely to present with high FBG (OR:
0.672 95% CI [0.441; 1.023]). The rest of the dietary factors
(protein, carbohydrates, PUFAs and MUFAs) were not
included in the OR model since they did not meet the
categorical data standard.
In summary, it seems as though high total dietary energy,
high added sugar intake, low ﬁbre, high SFA and trans fatty
acids increased the likelihood of participants presenting
with high WC, FBG, TCHOL, HDL-C, TG, LDL-C and
hypertension.
Discussion
Globally, the prevalence of the MetS is on the rise.
Developing countries in Africa, such as South Africa, is not
exempt from this. Interestingly, when the criteria for the
Joint Statement deﬁnition of MetS is applied in South
Africa, the MetS prevalence appears to be differentiated by
ethnicity in that it is higher in black ethnic groups (>60%)
compared to their white (±55%) counterparts [32]. How-
ever, when the criteria for IDF is applied, the prevalence is
lower in black ethnic groups (46.5%) compared to their
white counterparts (74.1%) [33]. Motala et al. (2011) [4] on
the other hand showed that the MetS prevalence differs
between genders in that more females (25, 21.2 and 16.8%)
present with MetS when compared to their male counter-
parts (10, 11.2 and 7.9%) when applying the criteria for the
JIS, IDF and ATP 111 deﬁnitions, respectively. Further-
more, when the criteria for the WHO deﬁnition is applied it
appears as though the prevalence of MetS is estimated to be
high (59.1%) in African countries such as Nigeria when
compared to other developing countries like Turkey (19%)
[34, 35]. However, when the NCEP-ATP III and IDF
deﬁnition criteria are used, the MetS prevalence is shown to
be higher in Turkey (38 and 42%, respectively) than in
Africa (i.e. in Cameroon, ±1% and ±11%, respectively) [35,
36]. This therefore shows that the differences in the MetS
prevalence observed in developing countries can be
explained by the deﬁnition for MetS that is applied, as well
as the gender and ethnicity of the population being studied
[37–39].
The current study population prevalence of MetS was
estimated using the IDF criteria, and overall, the prevalence
of MetS was 23.1% (8.6% males and 36.8 % females) [31]. Ta
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The risk of metabolic syndrome as a result of lifestyle among Ellisras rural young adults
This prevalence is lower than the prevalence shown in
South African coloured participants in the Erasmus et al.
(2011) [33] study, but higher than the prevalence shown in
black (9.5% for females and 6.8% for males) North West
residents participating in the Hoebel et al. (2011) [32] study.
Additionally, overall participants in the current study had a
higher MetS prevalence than that reported in low-income
black South Africans in the study by Owolabi et al. [40].
However, males in the current study had a lower MetS
prevalence than males in Owolabi et al’s study. We have to
bear in mind that the deﬁnition criteria used for MetS in
these studies were the IDF criteria. On examining factors
that seemed to inﬂuence MetS prevalence in the current
study, it appears as though age and gender were the main
determinants of this condition. In fact, being older inﬂu-
enced the health status of the participants especially the
mean SBP and adiposity as shown by the values that were
higher in the 25–30-year-old group than in the 18–24-year-
old group. The majority of females also presented with
larger WC and higher levels of TCHOL and lower levels of
HDL-C. The results of the current study are somewhat
corroborated by South African evidence that suggested that
in the North West province that is closer to Ellisras (Lim-
popo province) had the majority of females (43.5%) with
WC >88 cm when compared to 8% of males who present
with WC that are >102 cm [41]. In the same survey, the
mean SBP values also signiﬁcantly differed by gender, with
males presenting with higher mean values than females.
SBP and DBP also seemed to increase with age. However,
no signiﬁcant gender differences were observed in terms of
serum cholesterol.
Total energy intake in this study falls below the dietary
reference intakes for both males and females. However,
females tend to consume more energy than males. Con-
sumption of excessive dietary energy have been shown in
other studies conducted in black ethnic communities and
other rural areas in South Africa [15]. With regard to the
macronutrients consumed, females consumed more carbo-
hydrates, added sugar, ﬁbre, and saturated fat; while males
consumed more total fats. These eating behaviours may be
associated with the rapid nutrition transition in the country.
What was striking in the current ﬁndings was that partici-
pants in the current study consumed less dietary ﬁbre than
the recommended dietary allowances of 38 g for males and
25 g for females of this age group. This outcome is in line
with the outcomes of Wentzel-Viljoen et al. (2005) [42]
where they showed that ﬁbre intake is low in adults residing
in the North West province in South Africa. This is a cause
for concern given the increased beneﬁts that people are
likely to have if they consume this nutrient. In fact, sub-
stantiated evidence suggests that high dietary ﬁbre intake
lowers adiposity since it suppresses appetite [43]. More-
over, ﬁbre is beneﬁcial in that it expedites the movements of
waste products through the intestinal tract, thereby
decreasing the gut transit time to protect the gut from
harmful waste that may support the development of dif-
ferent forms of gut cancers [44] Moreover, dietary ﬁbre is
important in that it has antidiabetic properties, inhibits the
oxidation of LDL cholesterol, reduces platelet aggregation
and later reduces ischaemic damage [45].
Literature on the association between MetS risk factors
with dietary intakes is limited, particularly in the poor rural
populations [46]. In the current study, dietary ﬁbre was
signiﬁcantly associated with SBP and DBP. The same
ﬁnding was reported by Moreno Franco et al. (2014) [47].
An intervention study showed that increased dietary ﬁbre
intake signiﬁcantly reduced both DBP and SBP [48]. Fur-
ther, there was an association between dietary ﬁbre intake
and FBG among the current study participants. These
ﬁndings are consistent with the ﬁndings of Giacco et al.
(2000) [49] in that high dietary intake improves the blood
glucose level. The beneﬁcial metabolic effects of dietary
ﬁbre intake included both an improvement in the daily
blood glucose level and a reduction in the number of
hypoglycaemic events [49]. PUFAs was signiﬁcantly
associated with FBP, HDL-C and SBP. Food rich in PUFA
increases insulin sensitivity [50], glucose utilization and
decreases insulin resistance and the risk of type 2 diabetes
[51]. These results shows that PUFAs improves MetS risk
factors. Protein was also associated with SBP in the current
study. There is evidence that consumption of high protein
has a protective effect against the MetS [52]. However, this
association needs to be interpreted with caution given that
consuming higher than recommended amounts of protein is
associated with increased BP and hypertensive diseases [53]
and is therefore still controversial in the management of
MetS. In the current study, participants with a high energy
intake were less likely to present with a large WC, low
HDL-C and LDL-C. Similar results were reported by
Bruscato et al. (2010) [54]. These results may be attributed
to participants consuming less energy than recommended.
These results have a policy implication in that they call
upon urgent interventions including nutrition education in
rural and poorer communities of South Africa in order to
halt the escalating MetS epidemic as shown by a number of
studies in the country [55–57].
Limitations of the study
Adjusting for potential confounders boosted the strength of
the study results. Face-to-face 24-h dietary recall interviews
administered by trained interviewers on one weekday and
on one weekend day decreased the underestimation possi-
bility. However, 24-h dietary recall data for a 2-day period
is not adequate because dietary habits typically differ each
M. D. Sekgala et al.
day from those on other weekdays. Thus our 24-h dietary
recall data might have underestimated some nutrients as
well as energy intake. Despite the importance of the out-
comes of this study, authors also acknowledge the study
limitations such as the cross-sectional design; we therefore
cannot infer causality. Not all risk factors for MetS and
dietary intake were included in the current study. As such,
the current study focussed only on macronutrients. We
recommend that future studies examine the micronutrient
intake as this might show the utility. Considering of the
socio-economic status (SES) and physical activity could
have strengthened the ﬁndings. Therefore, future studies
should focus on the combination of both macronutrient and
micronutrient intake, SES and physical activity on the
inﬂuence of MetS risk factors.
Conclusion
MetS already appears to be entrenched in the rural com-
munities in South Africa. Females seem to be the most
vulnerable population group. In fact, the WC and HDL-C
levels seem to be the main risk factors that explain the
vulnerability of females to MetS compared to males. Males
in the current study showed vulnerability to elevation of BP.
The association between the dietary intake and MetS risk
factors is a useful tool that will inform targeted interven-
tions that may be useful in halting and eradicating MetS in a
country that is undergoing a rapid nutrition transition.
Moreover, identifying the groups that are at an increased
risk and those that are in their early stages of MetS will help
improve and prevent the increase of the MetS in future [58].
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